TRPV2 and bone disorder: This findings establish a novel mechano-pathological axis where diabetic ECM hyperviscosity propagates mechanical signals from cytoskeleton to chromatin through TRPV2 activation, proposing mechanomodulation as a promising therapeutic strategy for diabetic osteopathy.